GL1X · GenesisL1 explorer

MolNFT v1 · #159370 · protein

Crystal structure of HIV-1 LM/HT clade A/E CRF01 GP120 core in complex with (S)-mcg-III-188-A02.

6ONF · Clade A/E 93TH057 HIV-1 GP120 core: “Crystal structure of HIV-1 LM/HT clade A/E CRF01 GP120 core in complex with (S)-mcg-III-188-A02.”. X-ray diffraction, 2 ligands (MW4, NAG), 2 pockets (best druggability 0.56). MolNFT v1 #159370…

PDB
6ONF
Type
protein
Length
340 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Clade A/E 93TH057 HIV-1 GP120 core
UniProt
A0A0M3KKW9
Ligands
MW4, NAG
Pockets
2 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 17% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AClade A/E 93TH057 HIV-1 GP120 coreprotein34017% helix, 36% strandA0A0M3KKW9

Ligands and binding sites

  • MW4 · Ethyl (3S)-3-[(4-chloro-3-fluorophenyl) carbamoyl]piperidine-1-carboxylate · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 10 copies · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1680.560.8818MW4
2590.490.8518NAG

Modifications

Observed in the structure: 10 glycan, 8 disulfide (N-glycosylation, disulfide).

Compared structures

  • 6ONF · Crystal structure of HIV-1 LM/HT Clade A/E CRF01 gp120 core in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.